Provided by Tiger Fintech (Singapore) Pte. Ltd.

Athira Pharma, Inc.

0.3800
+0.02306.44%
Volume:31.75K
Turnover:11.86K
Market Cap:14.84M
PE:-0.18
High:0.3800
Open:0.3600
Low:0.3600
Close:0.3570
Loading ...
Jul 01, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 01, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 01, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 01, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 03, 2025

Major Issues Report

Form 8-K - Current report
May 09, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 09, 2025

Major Issues Report

Form 8-K - Current report
Apr 16, 2025

Major Issues Report

Form 8-K - Current report
Feb 28, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 28, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 28, 2025

Major Issues Report

Form 8-K - Current report
Jan 02, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 02, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 02, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 02, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 08, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 07, 2024

Major Issues Report

Form 8-K - Current report
Nov 07, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Oct 31, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]